Use of cryopreserved cells for enabling greater flexibility in compound profiling

Journal of Biomolecular Screening

Volumn 13, Issue 5, 2008, Pages 354-362

  Wigglesworth, M J ^a   Lawless, K J ^a   Standing, D J ^a   Mackenzie, E K ^a   Kitchen, V R ^a   McKay, F ^a   Ward, E ^a   Brough, S J ^a   Stylianou, M ^a   Jewitt, F R ^a   McLaren Douglas, A M ^a   Jowet, M I ^a   Tamayama, N ^a   Finnigan, D ^a   Ding, J ^b   Wise, A ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b Discovery Statistics   (United States)

Author keywords

Alpha 1A; Alpha 1B; Cryopreserved; FLIPR; Histamine

Indexed keywords

AZELASTINE; FEXOFENADINE; MEMBRANE PROTEIN; PRAZOSIN; QUETIAPINE; SEROTONIN 2A AGONIST; SEROTONIN 2A ANTAGONIST; SEROTONIN 2C AGONIST; SEROTONIN 2C ANTAGONIST; SEROTONIN ANTAGONIST; TRIPROLIDINE; ZIPRASIDONE;

ANALYTIC METHOD; ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CELL ASSAY; CELL CULTURE; CONTINUOUS CULTURE; CONTROLLED STUDY; CRYOPRESERVATION; FLUOROMETRY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CALCIUM; CHO CELLS; CRICETINAE; CRICETULUS; CRYOPRESERVATION; FLUOROMETRY; HUMANS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 44849103414     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057108317768     Document Type: Article

References (22)

1. Jerman JC, Brough SJ, Prinjha R., Harries MH, Davis JB, Smart D.: Characterization using FLIPR of rat vanilloid receptor (rVR1) pharmacology. Br J Pharmacol 2000 ; 130: 916-922.
2. Smart D., Jerman JC, Brough SJ, Rushton SL, Murdock PR, Jewitt F.,, et al. Characterization of recombinant human orexin receptor pharmacology in a Chinese hamster ovary cell-line using FLIPR. Br J Pharmacol 1999 ; 128: 1-3.
3. Sullivan E., Tucker EM, Dale IL: Measurement of [Ca2+] using the Fluorometric Imaging Plate Reader (FLIPR). Methods Mol Biol 1999 ; 114: 125-133.
4. Wagstaff R., Hedrick M., Fan J., Crowe PD, DiSepio D.: High-throughput screening for norepinephrine transporter inhibitors using the FLIPRTetra. J Biomol Screen 2007 ; 12: 436-441.
5. Whiteaker KL, Gopalakrishnan SM, Groebe D., Shieh CC, Warrior U., Burns DJ,, et al. Validation of FLIPR membrane potential dye for high throughput screening of potassium channel modulators. J Biomol Screen 2001 ; 6: 305-312.
6. Miret JJ, Zhang J., Min H., Lewis K., Roth M., Charlton M.,, et al. Multiplexed G-protein-coupled receptor Ca2+ flux assays for high-throughput screening. J Biomol Screen 2005 ; 10: 780-787.
7. Robas NM, Fidock MD: Identification of orphan G protein-coupled receptor ligands using FLIPR assays. Methods Mol Biol 2005 ; 306: 17-26.
8. Hodder P., Mull R., Cassaday J., Berry K., Strulovici B.: Miniaturization of intracellular calcium functional assays to 1536-well plate format using a fluorometric imaging plate reader. J Biomol Screen 2004 ; 9: 417-426.
9. Xin H., Wang Y., Todd MJ, Qi J., Minor LK: Evaluation of no-wash calcium assay kits: enabling tools for calcium mobilization. J Biomol Screen 2007 ; 12: 705-714.
10. Liu AM, Ho MK, Wong CS, Chan JH, Pau AH, Wong YH: Galpha(16/z) chimeras efficiently link a wide range of G protein-coupled receptors to calcium mobilization. J Biomol Screen 2003 ; 8: 39-49.
11. Ding M., Stjernborg L., Albertson N.: Application of cryopreserved cells to HERG screening using a non-radioactive Rb+ efflux assay. Assay Drug Dev Technol 2006 ; 4: 83-88.
12. Vana LM, Swales J., Hammond C., Wilson C., Hargreaves JA, Rostami-Hodjegan A.: Kinetics of the time-dependent inactivation of CYP2D6 in cryopreserved human hepatocytes by methylenedioxymethamphetamine (MDMA). Eur J Pharm Sci 2007 ; 31: 53-61.
13. Archer R.: An interview with Mr. Richard Archer former chief executive, The Automation Partnership, Cambridge, United Kingdom. Assay Drug Dev Technol 2004 ; 2: 603-608.
14. Zaman GJ, de Roos JA, Blomenrohr M., van Koppen CJ, Oosterom J.: Cryopreserved cells facilitate cell-based drug discovery. Drug Discov Today 2007 ; 12: 521-526.
15. Triggiani M., Gentile M., Secondo A., Granata F., Oriente A., Taglialatela M.,, et al. Histamine induces exocytosis and IL-6 production from human lung macrophages through interaction with H1 receptors. J Immunol 2001 ; 166: 4083-4091.
16. Fitzsimons CP, Monczor F., Fernandez N., Shayo C., Davio C.: Mepyramine, a histamine H1 receptor inverse agonist, binds preferentially to a G protein-coupled form of the receptor and sequesters G protein. J Biol Chem 2004 ; 279: 34431-34439.
17. van der Goot H., Timmerman H.: Selective ligands as tools to study histamine receptors. Eur J Med Chem 2000 ; 35: 5-20.
18. Chand N., Diamantis W., Sofia RD: Antagonism of histamine and leukotrienes by azelastine in isolated guinea pig ileum. Agents Actions 1986 ; 19: 164-168.
19. Arias-Montano JA, Berger VA, Soria-Jasso LE, Young JM: Characterisation of alpha1B-adrenoceptors linked to inositol phosphate formation and calcium mobilisation in human astrocytoma U373 MG cells. Naunyn Schmiedebergs Arch Pharmacol 1999 ; 360: 533-539.
20. Michel MC, Kenny B., Schwinn DA: Classification of alpha 1-adrenoceptor subtypes. Naunyn Schmiedebergs Arch Pharmacol 1995 ; 352: 1-10.
21. Daniels DV, Gever JR, Jasper JR, Kava MS, Lesnick JD, Meloy TD,, et al. Human cloned alpha1A-adrenoceptor isoforms display alpha1L-adrenoceptor pharmacology in functional studies. Eur J Pharmacol 1999 ; 370: 337-343.
22. Foglar R., Shibata K., Horie K., Hirasawa A., Tsujimoto G.: Use of recombinant alpha 1-adrenoceptors to characterize subtype selectivity of drugs for the treatment of prostatic hypertrophy. Eur J Pharmacol 1995 ; 288: 201-207.